pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Sanofi ($SNY) · news · pharmadog
← back to Sanofi
News mentioning $SNY
150
stories
May 8, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
May 8, 26
STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
stat
May 7, 26
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
stat
May 7, 26
Science is becoming less disruptive. Is an aging workforce to blame?
stat
May 7, 26
Official leading CDC’s cruise ship program retires
stat
May 7, 26
STAT+: More political interference at the FDA?
stat
May 7, 26
STAT+: Pharmalittle: We’re reading about Sanofi and an FDA voucher, FDA rethinking a rejection, and more
stat
May 6, 26
Trump administration’s drug strategy is at odds with recent actions on funding, policy
stat
May 6, 26
STAT+: Administration report on most favored nation drug pricing raises new details — and questions
stat
May 6, 26
Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer
onclive
May 6, 26
STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review
stat
May 4, 26
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
biopharma dive
Apr 29, 26
Teva nabs experimental Tourette drug in $700M Emalex buyout
biopharma dive
Apr 27, 26
STAT+: An insider reveals the real goals of prior authorization
stat
Apr 27, 26
STAT+: Astellas retries XLMTM gene therapy after deaths
stat
Apr 27, 26
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
stat
Apr 27, 26
STAT+: Veradermics’ hair loss drug succeeds in late-stage trial
stat
Apr 27, 26
STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study
stat
Apr 25, 26
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
endpoints
Apr 24, 26
STAT+: FDA to speed up review of three psychedelics as mental health treatments
stat
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
STAT+: Sanofi MS drug gets positive review in Europe following FDA
stat
Apr 24, 26
Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejection
endpoints
Apr 23, 26
STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead
stat
Apr 23, 26
STAT+: Sanofi research priorities in flux as new CEO logs in
stat
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
Apr 23, 26
Sanofi defends Garijo appointment, says it is 'fully committed' to immunology
endpoints
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
Apr 22, 26
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
← prev
page 5 of 5
next →
